Analyzing Tumor Cells for PD-L1 by IHC
Recorded On: 11/21/2018
PD-L1 is a protein that allows some cells to escape an attack by the immune system. Analyzing tumor cells for PD-L1 by IHC helps determine if patients will benefit from immune checkpoint inhibitors (cancer drugs). This webinar will discuss this protein and will include IHC technique, clinical features, and challenges and issues.
CEUs: This histology course is worth 1 continuing education credit. Course is available for 365 days from date of purchase.
Sherita specializes in translational molecular pathology with emphasis in immunohistochemistry. She also consults with researchers and clinicians regarding clinical trials and research protocols. She is also a clinical preceptor with MD Anderson’s School of Health Professions.